Krist Robert John 4
4 · ENDOLOGIX INC /DE/ · Filed Dec 31, 2012
Insider Transaction Report
Form 4
Krist Robert John
Chief Financial Officer
Transactions
- Sale
Common Stock
2012-12-28$14.20/sh−3,000$42,600→ 172,236 total - Sale
Common Stock
2012-12-28$14.00/sh−10,489$146,846→ 147,236 total - Sale
Common Stock
2012-12-28$14.33/sh−600$8,598→ 179,166 total - Sale
Common Stock
2012-12-28$14.03/sh−211$2,960→ 157,725 total - Award
Common Stock
2012-12-28$5.55/sh+37,530$208,292→ 179,766 total - Sale
Common Stock
2012-12-28$13.85/sh−5,000$69,250→ 142,236 total - Exercise/Conversion
Option to Purchase
2012-12-28−37,530→ 0 totalExercise: $5.55From: 2005-08-18Exp: 2014-08-18→ Common Stock (37,530 underlying) - Sale
Common Stock
2012-12-28$14.30/sh−3,930$56,199→ 175,236 total - Sale
Common Stock
2012-12-28$14.05/sh−10,000$140,500→ 157,936 total - Sale
Common Stock
2012-12-28$14.11/sh−4,300$60,673→ 167,936 total